FENC peer analysis
Fennec Pharmaceuticals (FENC) against its competitors: price, today's move, 1-year return and market value side by side.
FENC and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| AARD Aardvark Therapeutics | $1.17 | -7.14% | -88.89% | $26.41M |
| AVTX Avalo Therapeutics | $6.99 | -5.16% | -50.92% | $418.06M |
| BDTX Black Diamond | $1.44 | -5.88% | -66.59% | $86.20M |
| CRBU Caribou Biosciences | $0.35 | -1.81% | -82.47% | $37.60M |
| ENTA Enanta Pharmaceuticals | $8.96 | -16.03% | -4.44% | $326.20M |
| EPRX Eupraxia | $6.91 | -5.86% | 15.46% | $492.21M |
| NAUT Nautilus Biotechnology | $2.36 | 12.38% | 12.63% | $271.14M |
| OBIO Orchestra BioMed | $7.24 | 1.69% | 70.33% | $560.38M |
| PRLD Prelude Therapeutics | $3.30 | -3.23% | 121.85% | $267.34M |
| RNAC Cartesian Therapeutics | $6.08 | -4.25% | -12.17% | $193.69M |
| FENC Fennec Pharmaceuticals | $13.40 | 5.02% | 65.15% | $448.37M |
- FENC's peers: AARD (Aardvark Therapeutics), AVTX (Avalo Therapeutics), BDTX (Black Diamond), CRBU (Caribou Biosciences), ENTA (Enanta Pharmaceuticals), EPRX (Eupraxia), NAUT (Nautilus Biotechnology), OBIO (Orchestra BioMed).
Updated 2026-11-17 17:46 UTC